BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 78
New Positions 9
Increased Positions 36
Decreased Positions 25
Positions with Activity 61
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,287

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.69%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.24%
Healthcare 86.71%
Services 0%
Technology
Transportation
Utilities

9 New Positions as of 12/31/2014

Company Class ▲ Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held
ADMA BIOLOGICS INC COM 3,114 3,114 New 389,193
AUSPEX PHARMACEUTICALS INC COM 10,096 10,096 New 100,000
HEARTWARE INTL INC COM 3,748 3,748 New 50,000
MASIMO CORP COM 3,385 3,385 New 97,900
PARATEK PHARMACEUTICALS INC COM 7,043 7,043 New 260,283
RAPTOR PHARMACEUTICAL CORP COM 150 150 New 15,558
LIGAND PHARMACEUTICALS INC COM NEW 15,456 15,456 New 199,000
MEDGENICS INC COM NEW 8,210 8,210 New 1,025,000
AMARIN CORP PLC SPONS ADR NEW 4,244 4,244 New 2,233,746


Latest News Headlines

View All Latest Headlines
Create your free portfolio